Inventor · disambiguated record
Lixin Qiao
Also filed as: QIAO LIXIN
45 granted patents·13 pending applications·869 citations·filing 1998–2023
98Inventor score
Files withCELGENE AVILOMICS RES INC17CELGENE CAR LLC12NIU DEQIANG5MASSACHUSETTS EYE & EAR INFIRMARY3NEUROLOGIC INC3
Top patents by PatentIndex Score
58 records- 0199US8609679B22,4-diaminopyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 17, 2013·84 cites·4 claims
- 0298US8710222B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Apr 29, 2014·52 cites·3 claims
- 0398US8450335B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted May 28, 2013·130 cites·22 claims
- 0498US8338439B22,4-disubstituted pyrimidines useful as kinase inhibitorsSINGH JUSWINDER·Filed 2009·Granted Dec 25, 2012·175 cites·2 claims
- 0597US9987276B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jun 5, 2018·23 cites·26 claims
- 0696US9561228B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Feb 7, 2017·37 cites·17 claims
- 0796US9212181B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Dec 15, 2015·34 cites·42 claims
- 0895US10010548B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2016·Granted Jul 3, 2018·15 cites·4 claims
- 0995US9409921B22,4-disubstituted pyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2014·Granted Aug 9, 2016·25 cites·2 claims
- 1095US9296737B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE AVILOMICS RES INC·Filed 2012·Granted Mar 29, 2016·27 cites·23 claims
- 1194US9145387B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Sep 29, 2015·21 cites·28 claims
- 1293US9980964B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2017·Granted May 29, 2018·11 cites·28 claims
- 1393US8980935B2HCV protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Mar 17, 2015·7 cites·26 claims
- 1493US8741837B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Jun 3, 2014·10 cites·23 claims
- 1593US8309685B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2009·Granted Nov 13, 2012·20 cites·36 claims
- 1692US9504686B2ERK inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Nov 29, 2016·10 cites·40 claims
- 1792US8524760B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Sep 3, 2013·9 cites·13 claims
- 1892US8293705B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted Oct 23, 2012·12 cites·15 claims
- 1992US8188137B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted May 29, 2012·13 cites·29 claims
- 2091US9796700B2ERK inhibitors and uses thereofCELGENE CAR LLC·Filed 2016·Granted Oct 24, 2017·7 cites·17 claims
- 2191US8188131B2Compounds that enhance Atoh1 expressionEDGE ALBERT·Filed 2009·Granted May 29, 2012·19 cites·34 claims
- 2290US11351168B12,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2020·Granted Jun 7, 2022·2 cites·3 claims
- 2390US10828300B2Substituted 2,4-diaminopyrimidines as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Nov 10, 2020·3 cites·27 claims
- 2490US10596172B22,4-disubstituted pyrimidines useful as kinase inhibitorsCELGENE CAR LLC·Filed 2018·Granted Mar 24, 2020·5 cites·3 claims
- 2589US10406163B2Compounds that enhance Atoh1 expressionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted Sep 10, 2019·6 cites·3 claims
- 2689US10138256B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2014·Granted Nov 27, 2018·11 cites·12 claims
- 2788US8778877B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2008·Granted Jul 15, 2014·10 cites·26 claims
- 2885US9422333B2HCV protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Aug 23, 2016·2 cites·19 claims
- 2985US6562783B2Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as β-secretase inhibitorsNEUROLOGIC INC·Filed 2001·Granted May 13, 2003·19 cites·8 claims
- 3083US8859597B2Compounds that enhance Atoh1 expressionEDGE ALBERT·Filed 2012·Granted Oct 14, 2014·5 cites·30 claims
- 3181US9163061B2HCV protease inhibitors and uses thereofPETTER RUSSELL C·Filed 2008·Granted Oct 20, 2015·5 cites·31 claims
- 3281US8354116B2Bifunctional synthetic moleculesBIOCHEMICS INC·Filed 2007·Granted Jan 15, 2013·4 cites·4 claims
- 3378US9556426B2Protein kinase conjugates and inhibitorsSINGH JUSWINDER·Filed 2010·Granted Jan 31, 2017·3 cites·48 claims
- 3476US5962504ASubstituted 2-pyrrolidinone activators of PKCUNIV GEORGETOWN·Filed 1998·Granted Oct 5, 1999·35 cites·16 claims
- 3575US11160808B2Compounds that enhance Atoh1 expressionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted Nov 2, 2021·0 cites·8 claims
- 3674US10662195B2Protein kinase conjugates and inhibitorsCELGENE AVILOMICS RES INC·Filed 2016·Granted May 26, 2020·1 cites·1 claims
- 3774US8927545B2Inhibiting Eph B-3 kinaseQIAO LIXIN·Filed 2010·Granted Jan 6, 2015·7 cites·15 claims
- 3869US11542492B2Ligand-directed covalent modification of proteinCELGENE CAR LLC·Filed 2017·Granted Jan 3, 2023·1 cites·7 claims
- 3966US2015031106A1Hcv protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Application pending·0 cites
- 4064US9433610B2Compounds that enhance Atoh1 expressionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2014·Granted Sep 6, 2016·0 cites·25 claims
- 4164US6667340B1Inhibitors of phosphatidyl myo-inositol cycleUNIV ARIZONA·Filed 2001·Granted Dec 23, 2003·2 cites·9 claims
- 4263US2016326216A1Hcv protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2016·Application pending·0 cites
- 4360US11098061B2MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2018·Granted Aug 24, 2021·0 cites·14 claims
- 4460US2017137463A1Hcv protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2016·Application pending·0 cites
- 4560US2024190890A1Mk2 inhibitors and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4659US7153843B2Inhibitors of phosphatidyl myo-inositol cycleUNIV ARIZONA·Filed 2003·Granted Dec 26, 2006·1 cites·18 claims
- 4758US2013131105A1Hcv protease inhibitors and uses thereofCELGENE AVILOMICS RES INC·Filed 2012·Application pending·0 cites
- 4857US2007213398A1Inhibitors of phosphatidyl myo-inositol cycleKOZIKOWSKI ALAN P·Filed 2006·Application pending·0 cites
- 4955US9694086B2HCV protease inhibitors and uses thereofCELGENE CAR LLC·Filed 2015·Granted Jul 4, 2017·0 cites·18 claims
- 5055US9676785B2HCV protease inhibitors and uses thereofCELGENE CAR LLC·Filed 2014·Granted Jun 13, 2017·0 cites·32 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lixin Qiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →